Phenotype of Tumor-Associated Antigen Presenting Cells after Blocking Indoleamine 2-3-Dioxygenase |
Augusta University |
Northwestern Mutual Foundation |
Characterizing PPM1D Mutations as Oncogenic Drivers of Diffuse Intrinsic Pontine Glioma |
Brown University |
Northwestern Mutual Foundation |
Targeting SHP2 in Receptor Tyrosine Kinase-driven Neuroblastomas |
University of Pennsylvania |
Northwestern Mutual Foundation |
The Role of Neuropeptide Y and Its Y5 Receptor in Dissemination of Refractory Neuroblastoma |
Georgetown University |
Northwestern Mutual Foundation |
Quantitative Evaluation of CAR-T Cell Inhibition Mediated by PD1 |
University of Michigan |
Northwestern Mutual Foundation |
Identifying Drivers of Ewing sarcoma Using Engineered iPSC of European and African Ancestry |
Grinnell College |
Northwestern Mutual Foundation |
Phase I Study of Lentivirus Engineered Autologous AML Cells Expressing IL-12 in Children and Young Adults with Relapsed AML |
Children’s Hospital of Wisconsin - Milwaukee |
Northwestern Mutual Foundation |
Development of Mithramycin Analogs for Ewing sarcoma |
Van Andel Research Institute |
Northwestern Mutual Foundation |
Adoptive Cell Therapy Against Brain Stem Gliomas |
University of Florida |
Northwestern Mutual Foundation |
Investigating the Effects of Indoleamine 2-3-Dioxygenase Pathway Blockers in Combination with Chemotherapy and Radiation Treatments on Complement Production in Dendritic Cells and Macrophages |
Augusta University |
Northwestern Mutual Foundation |